Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
United States Army Institute of Surgical Research |
---|---|
Information provided by: | United States Army Institute of Surgical Research |
ClinicalTrials.gov Identifier: | NCT00243243 |
The purpose of the study is to see if a medication (Recombinant Coagulation Factor VIIa or NovoSeven), normally used to stop bleeding in persons with a bleeding disorder, will lower the amount of blood lost during burn surgery.
Condition | Intervention | Phase |
---|---|---|
Burns |
Drug: Recombinant Factor VIIa |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Effect of Recombinant Coagulation Factor VIIa on Peri-Operative Blood Loss in Patients Undergoing Major Burn Excision and Grafting |
Estimated Enrollment: | 52 |
Study Start Date: | January 2006 |
Estimated Study Completion Date: | December 2010 |
Estimated Primary Completion Date: | September 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Experimental |
Drug: Recombinant Factor VIIa
intravenous infusion of Factor VIIa
|
To identify the clinical use for Factor VIIa in the operating room to reduce blood loss and blood transfusion , determine the Recombinant Factor VIIa (rFVIIa) pharmacokinetics in burned patients, determine if fFVIIa should be used to reduce peri-operative blood loss in patients undergoing excision greater than or equal to 20 percent of the total body surface area, determine the efficacy of the drug in burned patients undergoing excision of burn wounds.
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Chaya Galin, RN | 210-916-7154 | chaya.galin@amedd.army.mil |
Contact: Michelle Morrow, RN | 210-916-8147 | michelle.morrow@amedd.army.mil |
United States, Texas | |
United States Army Institute of Surgical Research | Recruiting |
Ft Sam Houston, Texas, United States, 78234 | |
Contact: Annette R McClinton, RN, MA 210-916-2834 Annette.McClinton@amedd.army.mil | |
Contact: Nancy C Molter, RN, PhD 210-916-5690 Nancy.Molter@amedd.army.mil |
Principal Investigator: | Myung S Park, MD | United States Army Institute of Surgical Research |
Responsible Party: | USAISR ( Myung Park, LTC, MC ) |
Study ID Numbers: | H-05-027 |
Study First Received: | October 19, 2005 |
Last Updated: | January 15, 2009 |
ClinicalTrials.gov Identifier: | NCT00243243 |
Health Authority: | United States: Federal Government |
Burns |
Burns Wounds and Injuries Disorders of Environmental Origin Hemorrhage |